Page 50 - IMO-2-2
P. 50

Innovative Medicines & Omics                                           Alzheimer’s disease and clinical trials



               doi: 10.1016/j.drudis.2022.01.016                  doi: 10.31887/DCNS.2019.21.1/vharoutunian
            15.  Dokholyan  NV,  Mohs  RC,  Bateman  RJ.  Challenges  and   26.  Xiao D, Zhang C. Current therapeutics for Alzheimer’s
               progress in research, diagnostics, and therapeutics in   disease and clinical trials. Explor Neurosci. 2024;3:255-271.
               Alzheimer’s  disease  and  related  dementias.  Alzheimers
               Dement (N Y). 2022;8:e12330.                       doi: 10.37349/en.2024.00048
                                                               27.  Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation
               doi: 10.1002/trc2.12330
                                                                  in neurodegenerative diseases: Current understanding
            16.  Frozza RL, Lourenco MV, De Felice FG. Challenges   and future therapeutic targets.  Front Aging Neurosci.
               for  Alzheimer’s  disease  therapy: Insights from  Novel   2024;16:1347987.
               mechanisms beyond memory defects.  Front Neurosci.
               2018;12:37.                                        doi: 10.3389/fnagi.2024.1347987
                                                               28.  Kinney JW, Bemiller SM, Murtishaw AS, Leisgang
               doi: 10.3389/fnins.2018.00037
                                                                  AM, Salazar AM, Lamb BT. Inflammation as a central
            17.  Huang LK, Kuan YC, Lin HW, Hu CJ. Clinical trials of new   mechanism in Alzheimer’s disease. Alzheimers Dement (N
               drugs for Alzheimer disease: A 2020-2023 update. J Biomed   Y). 2018;4:575-590.
               Sci. 2023;30:83.
                                                                  doi: 10.1016/j.trci.2018.06.014
               doi: 10.1186/s12929-023-00976-6
                                                               29.  McGeer PL, Rogers J. Anti-inflammatory agents as a
            18.  Ahmad MA, Kareem O, Khushtar M,  et al.          therapeutic approach to Alzheimer’s disease.  Neurology.
               Neuroinflammation: A potential risk for dementia. Int J Mol   1992;42:447-449.
               Sci. 2022;23:616.
                                                                  doi: 10.1212/wnl.42.2.447
               doi: 10.3390/ijms23020616
                                                               30.  Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D.
            19.  Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation   Inflammation in Alzheimer’s disease: Relevance to
               in Alzheimer’s disease. Lancet Neurol. 2015;14:388-405.  pathogenesis and therapy. Alzheimers Res Ther. 2010;2:1.

               doi: 10.1016/S1474-4422(15)70016-5                 doi: 10.1186/alzrt24
            20.  Lecca D, Jung YJ, Scerba MT,  et al. Role of chronic   31.  Gassowska-Dobrowolska M, Chlubek M, Kolasa A,
               neuroinflammation in neuroplasticity and cognitive function:   et al. Microglia and astroglia-the potential role in
               A hypothesis. Alzheimers Dement. 2022;18:2327-2340.  neuroinflammation induced by pre- and neonatal exposure
               doi: 10.1002/alz.12610                             to lead (Pb). Int J Mol Sci. 2023;24:9903.
            21.  Leng F, Edison P. Neuroinflammation and microglial      doi: 10.3390/ijms24129903
               activation in Alzheimer disease: Where do we go from here?   32.  Liddelow SA, Barres BA. Reactive astrocytes: Production,
               Nat Rev Neurol. 2021;17:157-172.                   function, and therapeutic potential. Immunity. 2017;46:957-967.
               doi: 10.1038/s41582-020-00435-y                    doi: 10.1016/j.immuni.2017.06.006
            22.  Lopez-Rodriguez AB, Hennessy E, Murray CL, et al. Acute   33.  Wang YW, Zhou Q, Zhang X,  et al. Correction to: Mild
               systemic inflammation exacerbates neuroinflammation   endoplasmic reticulum stress ameliorates lipopolysaccharide-
               in Alzheimer’s disease: IL-1β drives amplified responses   induced neuroinflammation and cognitive impairment via
               in primed astrocytes and neuronal network dysfunction.   regulation of microglial polarization. J Neuroinflammation.
               Alzheimers Dement. 2021;17:1735-1755.              2020;17:353.
               doi: 10.1002/alz.12341                             doi: 10.1186/s12974-020-01990-3
            23.  Sobue A, Komine O, Yamanaka K. Neuroinflammation in   34.  Kumar A. Editorial: Neuroinflammation and cognition.
               Alzheimer’s disease: Microglial signature and their relevance   Front Aging Neurosci. 2018;10:413.
               to disease. Inflamm Regen. 2023;43:26.
                                                                  doi: 10.3389/fnagi.2018.00413
               doi: 10.1186/s41232-023-00277-3
                                                               35.  Amin J, Gee C, Stowell K, Coulthard D, Boche D.
            24.  Bettcher  BM,  Tansey  MG,  Dorothee  G,  Heneka  MT.   T  Lymphocytes  and their  potential  role  in  dementia  with
               Peripheral and central immune system crosstalk in   lewy bodies. Cells. 2023;12:2253.
               Alzheimer disease - a research prospectus. Nat Rev Neurol.
               2021;17:689-701.                                   doi: 10.3390/cells12182283
               doi: 10.1038/s41582-021-00549-x                 36.  Chen N, Caruso C, Alonso A, et al. Association of sickle cell
                                                                  trait with measures of cognitive function and dementia in
            25.  Katsel P, Haroutunian V. Is Alzheimer disease a failure of
               mobilizing immune defense? Lessons from cognitively fit   African Americans. eNeurologicalSci. 2019;16:100201.
               oldest-old. Dialogues Clin Neurosci. 2019;21:7-19.     doi: 10.1016/j.ensci.2019.100201


            Volume 2 Issue 2 (2025)                         44                          doi: 10.36922/IMO025050007
   45   46   47   48   49   50   51   52   53   54   55